NatashaRekhtmanMD

Cytopathology, Pulmonary Pathology, Anatomic Pathology, Clinical Pathology

Physician

Dr. Rekhtman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

1 citations
High-risk features associated with recurrence in stage I lung adenocarcinoma.
Cameron N Fick, Elizabeth G Dunne, Stijn Vanstraelen, Nicolas Toumbacaris, Kay See Tan
The Journal of Thoracic and Cardiovascular Surgery. 2025-02-01
3 citations
Chromothripsis-Mediated Small Cell Lung Carcinoma.
Natasha Rekhtman, Sam E Tischfield, Christopher A Febres-Aldana, Jake June-Koo Lee, Jason C Chang
Cancer Discovery. 2025-01-13
Expression and Clinical Outcome in Pulmonary Carcinoids.
Lisa Werr, Christoph Bartenhagen, Carolina Rosswog, Maria Cartolano, Catherine Voegele
Journal of Clinical Oncology. 2025-01-10

Journal Articles

PD-L1 Expression, Tumor Mutational Burden, and Response to Immunotherapy in Patients with MET Exon 14 Altered Lung Cancers
G J Riely, J Dienstag, C Mrad, J K Sabari, M G Kris, K C Arbour, D F Halpenny, N Rekhtman, R Chen, A J Plodkowski, P K Paik, B T Li, I Bergagnini, M D Offin, C M Rudin..., Annals of Oncology
Pathologic Features of Response to Neoadjuvant Anti-PD-1 in Resected Non-Small Cell Lung Carcinoma: A Proposal for Quantitative Immune-Related Pathologic Response Crit...
J M Isbell, N Rekhtman, J D Wolchok, J E Chaft, Annals of Oncology